Notis McConarty Edward acquired a new position in shares of Cerner Corporation (NASDAQ:CERN) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,000 shares of the company’s stock, valued at approximately $214,000.
Other hedge funds have also bought and sold shares of the company. Andra AP fonden boosted its holdings in shares of Cerner Corporation by 45.8% during the second quarter. Andra AP fonden now owns 30,900 shares of the company’s stock worth $2,054,000 after purchasing an additional 9,700 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Cerner Corporation by 7.4% during the second quarter. Dimensional Fund Advisors LP now owns 697,200 shares of the company’s stock worth $46,342,000 after purchasing an additional 47,812 shares during the last quarter. State Farm Mutual Automobile Insurance Co. boosted its holdings in shares of Cerner Corporation by 381.0% during the second quarter. State Farm Mutual Automobile Insurance Co. now owns 429,846 shares of the company’s stock worth $28,572,000 after purchasing an additional 340,486 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its holdings in shares of Cerner Corporation by 2.6% during the second quarter. Schwab Charles Investment Management Inc. now owns 937,175 shares of the company’s stock worth $62,295,000 after purchasing an additional 23,659 shares during the last quarter. Finally, IBM Retirement Fund boosted its holdings in shares of Cerner Corporation by 114.6% during the second quarter. IBM Retirement Fund now owns 7,038 shares of the company’s stock worth $523,000 after purchasing an additional 3,759 shares during the last quarter. Institutional investors and hedge funds own 78.90% of the company’s stock.
In other Cerner Corporation news, SVP Randy D. Sims sold 60,000 shares of the business’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $68.03, for a total transaction of $4,081,800.00. Following the completion of the transaction, the senior vice president now owns 60,890 shares of the company’s stock, valued at approximately $4,142,346.70. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Michael Nill sold 99,470 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $70.45, for a total transaction of $7,007,661.50. The disclosure for this sale can be found here. Insiders sold 371,583 shares of company stock valued at $24,758,191 over the last quarter. 13.20% of the stock is currently owned by corporate insiders.
CERN has been the topic of several analyst reports. Royal Bank Of Canada restated a “buy” rating on shares of Cerner Corporation in a report on Wednesday, October 25th. Robert W. Baird restated a “hold” rating and set a $67.00 price objective on shares of Cerner Corporation in a report on Thursday, August 31st. J P Morgan Chase & Co cut Cerner Corporation from an “overweight” rating to a “neutral” rating in a report on Friday. Zacks Investment Research cut Cerner Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, September 26th. Finally, Cantor Fitzgerald restated a “buy” rating and set a $77.00 price objective on shares of Cerner Corporation in a report on Tuesday, October 10th. Fifteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Cerner Corporation presently has an average rating of “Hold” and a consensus price target of $69.05.
Cerner Corporation (NASDAQ CERN) traded up 0.46% on Monday, reaching $65.61. The company’s stock had a trading volume of 797,907 shares. The company has a market capitalization of $21.76 billion, a price-to-earnings ratio of 33.15 and a beta of 0.95. Cerner Corporation has a 1-year low of $47.01 and a 1-year high of $73.86. The stock has a 50 day moving average price of $71.12 and a 200-day moving average price of $66.32.
Cerner Corporation (NASDAQ:CERN) last issued its quarterly earnings data on Thursday, October 26th. The company reported $0.61 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.62 by ($0.01). The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.29 billion. Cerner Corporation had a return on equity of 18.03% and a net margin of 13.37%. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.59 earnings per share. Equities analysts predict that Cerner Corporation will post $2.50 earnings per share for the current fiscal year.
About Cerner Corporation
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
What are top analysts saying about Cerner Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cerner Corporation and related companies.